<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37245090</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8249</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of neurology</Title><ISOAbbreviation>Ann Neurol</ISOAbbreviation></Journal><ArticleTitle>Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>547</StartPage><EndPage>560</EndPage><MedlinePgn>547-560</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ana.26714</ELocationID><Abstract><AbstractText>Platform trials allow efficient evaluation of multiple interventions for a specific disease. The HEALEY ALS Platform Trial is testing multiple investigational products in parallel and sequentially in persons with amyotrophic lateral sclerosis (ALS) with the goal of rapidly identifying novel treatments to slow disease progression. Platform trials have considerable operational and statistical efficiencies compared with typical randomized controlled trials due to their use of shared infrastructure and shared control data. We describe the statistical approaches required to achieve the objectives of a platform trial in the context of ALS. This includes following regulatory guidance for the disease area of interest and accounting for potential differences in outcomes of participants within the shared control (potentially due to differences in time of randomization, mode of administration, and eligibility criteria). Within the HEALEY ALS Platform Trial, the complex statistical objectives are met using a Bayesian shared parameter analysis of function and survival. This analysis serves to provide a common integrated estimate of treatment benefit, overall slowing in disease progression, as measured by function and survival while accounting for potential differences in the shared control group using Bayesian hierarchical modeling. Clinical trial simulation is used to provide a better understanding of this novel analysis method and complex design. ANN NEUROL 2023;94:547-560.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quintana</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Berry Consultants, Austin, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saville</LastName><ForeName>Benjamin R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Berry Consultants, Austin, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vestrucci</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Berry Consultants, Austin, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Detry</LastName><ForeName>Michelle A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Berry Consultants, Austin, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chibnik</LastName><ForeName>Lori</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shefner</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Sean M. Healey &amp; AMG Center for ALS at Mass General, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chase</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sean M. Healey &amp; AMG Center for ALS at Mass General, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrews</LastName><ForeName>Jinsy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurological Institute of New York, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherman</LastName><ForeName>Alexander V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Sean M. Healey &amp; AMG Center for ALS at Mass General, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Sean M. Healey &amp; AMG Center for ALS at Mass General, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drake</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sean M. Healey &amp; AMG Center for ALS at Mass General, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cudkowicz</LastName><ForeName>Merit</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7075-1681</Identifier><AffiliationInfo><Affiliation>Sean M. Healey &amp; AMG Center for ALS at Mass General, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paganoni</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sean M. Healey &amp; AMG Center for ALS at Mass General, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macklin</LastName><ForeName>Eric A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>HEALEY ALS Platform Trial Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Neurol</MedlineTA><NlmUniqueID>7707449</NlmUniqueID><ISSNLinking>0364-5134</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Macklin</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hayden</LastName><ForeName>Douglas</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lai</LastName><ForeName>PoYing</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donahue</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marion</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alameda</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathai</LastName><ForeName>Nithya</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ho</LastName><ForeName>Doreen</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCaffrey</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berry</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Babu</LastName><ForeName>Suma</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scalia</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Freeman</LastName><ForeName>Marlene</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tourenne</LastName><ForeName>Clotilde Lagier</ForeName><Initials>CL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sadri-Vakili</LastName><ForeName>Ghazaleh</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quick</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kolb</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heintzman</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heitzman</LastName><ForeName>Daragh</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ajroud-Driss</LastName><ForeName>Senda</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sufit</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Szymanski</LastName><ForeName>April</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Appel</LastName><ForeName>Stanley H</ForeName><Initials>SH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greene</LastName><ForeName>Ericka Simpson</ForeName><Initials>ES</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thonhoff</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shroff</LastName><ForeName>Sheetal</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liao</LastName><ForeName>Bing</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Katz</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Liberty</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Felice</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whitaker</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maragakis</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clawson</LastName><ForeName>Lora L</ForeName><Initials>LL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uchil</LastName><ForeName>Alpa</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riley</LastName><ForeName>Kristen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arneklev</LastName><ForeName>JinAe</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simmons</LastName><ForeName>Zachary</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grogan</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Su</LastName><ForeName>Xiaowei</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mamarabadi</LastName><ForeName>Mansoureh</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goutman</LastName><ForeName>Stephen A</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feldman</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olney</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bazan</LastName><ForeName>Tracy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malcolm</LastName><ForeName>Amber</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Joseph Americo M</ForeName><Initials>JAM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piccione</LastName><ForeName>Ezequiel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thaisetthawatkul</LastName><ForeName>Pariwat</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ilieva</LastName><ForeName>Hristelina</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasinelli</LastName><ForeName>Piera</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jawdat</LastName><ForeName>Omar</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farmakidis</LastName><ForeName>Constantine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jabari</LastName><ForeName>Duaa</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Statland</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasnoor</LastName><ForeName>Mamatha</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dimachkie</LastName><ForeName>Mazen</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weiss</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rad</LastName><ForeName>Nassim</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Leo H</ForeName><Initials>LH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foster</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vu</LastName><ForeName>Tuan</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suresh</LastName><ForeName>Niraja</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farias</LastName><ForeName>Jerrica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ladha</LastName><ForeName>Shafeeq</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jacobsen</LastName><ForeName>Bill</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milliard</LastName><ForeName>Jourdan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bowser</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Owegi</LastName><ForeName>Margaret Ayo</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Ghasemi</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Houmani</LastName><ForeName>Hajar</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douthwright</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newman</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arcila-Londono</LastName><ForeName>Ximena</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steijlen</LastName><ForeName>Kara</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yasek</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hams</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Carlayne</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhavaraju-Sanka</LastName><ForeName>Ratna</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swenson</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nance</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gutmann</LastName><ForeName>Ludwig</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heiman-Patterson</LastName><ForeName>Terry</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deboo</LastName><ForeName>Anahita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caress</LastName><ForeName>Jim</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cartwright</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fee</LastName><ForeName>Dominic</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shrilla</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peltier</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burford</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diaz</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosenfeld</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borg</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhuvaneswaran</LastName><ForeName>Karthikeyan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walk</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maiser</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kristin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rao</LastName><ForeName>Pooja</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elliott</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rakocevic</LastName><ForeName>Goran</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Solorzano</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kasarskis</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahuwala</LastName><ForeName>Zabeen</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathur Kumaraswamy</LastName><ForeName>Vishakhadatta Vish</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rutkove</LastName><ForeName>Seward</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIlduff</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bedlack</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parker</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elman</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quinn</LastName><ForeName>Colin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goyal</LastName><ForeName>Namita A</ForeName><Initials>NA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Habib</LastName><ForeName>Ali A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mozaffar</LastName><ForeName>Tahseen</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korb</LastName><ForeName>Manisha Kak</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mullen</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rezania</LastName><ForeName>Kourosh</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soliven</LastName><ForeName>Betty</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roos</LastName><ForeName>Raymond</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Twydell</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mundwiler</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Young</LastName><ForeName>Eufrosina</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyer</LastName><ForeName>Jenny A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benatar</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glass</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fournier</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cohen</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stommel</LastName><ForeName>Elijah</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robbins</LastName><ForeName>Nathaniel M</ForeName><Initials>NM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Vovanti</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zilliox</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diaz-Abad</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jin</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chauhan</LastName><ForeName>Chandana</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wymer</LastName><ForeName>James P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chuquilin</LastName><ForeName>Miguel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Subramony</LastName><ForeName>S H</ForeName><Initials>SH</Initials></Investigator><Investigator ValidYN="Y"><LastName>McNeely</LastName><ForeName>Whitney</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beydoun</LastName><ForeName>Said R</ForeName><Initials>SR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Darki</LastName><ForeName>Leila</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shah</LastName><ForeName>Jaimin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oskarsson</LastName><ForeName>Bjorn</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pattee</LastName><ForeName>Gary L</ForeName><Initials>GL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bobenhouse</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hayat</LastName><ForeName>Ghazala</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Al-Dahhak</LastName><ForeName>Roula</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kafaie</LastName><ForeName>Jafar</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinez-Thompson</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Staff</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nayar</LastName><ForeName>Shakti</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuenzler</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bayat</LastName><ForeName>Elham</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosow</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bodkin</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gursoy</LastName><ForeName>Nurcan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Al-Lahham</LastName><ForeName>Tawfiq</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lacomis</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gibson</LastName><ForeName>Summer</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivner</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kushlaf</LastName><ForeName>Hani A</ForeName><Initials>HA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gwathmey</LastName><ForeName>Kelly G</ForeName><Initials>KG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elliott</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKinnon</LastName><ForeName>Johnathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Abel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walsh</LastName><ForeName>Alison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whitesell</LastName><ForeName>Jackie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erickson</LastName><ForeName>Amber</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Locatelli</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Connors</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCluskey</LastName><ForeName>Leo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Usman</LastName><ForeName>Uzma</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kovvuru</LastName><ForeName>Sukanthi</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sherman</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hasenoehrl</LastName><ForeName>Meredith</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dagostino</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faulconer</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kharakozova</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korin</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tarasenko</LastName><ForeName>Natalia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vigneswaran</LastName><ForeName>Prasha</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Katsovskiy</LastName><ForeName>Igor</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whitworth</LastName><ForeName>Isaac</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wahab</LastName><ForeName>Yusra</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Novak</LastName><ForeName>Ilya</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tustison</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jentoft</LastName><ForeName>Katie</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ostrow</LastName><ForeName>Joe</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Changkuon</LastName><ForeName>Genevive</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>La</LastName><ForeName>Thuong</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deignan</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Haining</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Payal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phan</LastName><ForeName>Minh</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hurwitz</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Estes</LastName><ForeName>Michaela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Palillo</LastName><ForeName>Jack</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomas</LastName><ForeName>Mirna</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Mattos</LastName><ForeName>Annette</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patterson</LastName><ForeName>Janae</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Figueroa-Szostek</LastName><ForeName>Precious</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jean</LastName><ForeName>Sandra Louis</ForeName><Initials>SL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pothier</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harkey</LastName><ForeName>Brittney</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>DiStefano</LastName><ForeName>Sofia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bailey</LastName><ForeName>Abbey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jordan</LastName><ForeName>Boglarka</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pagliaro</LastName><ForeName>Jaclyn</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wright</LastName><ForeName>Spencer</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abu-Hamdan</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Igne</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kolvek</LastName><ForeName>Taylor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bailey</LastName><ForeName>Jesse</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barlow</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arroyave</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henrique</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Proeung</LastName><ForeName>Serena</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>Jesse</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gladden</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cirino</LastName><ForeName>Melissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henrique</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deirmendjian</LastName><ForeName>Emma</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Small</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bulat</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hurwitz</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Popel</LastName><ForeName>Najla</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Irwin</LastName><ForeName>Liam</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hall</LastName><ForeName>Meghan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Connolly</LastName><ForeName>Mariah</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kittle</LastName><ForeName>Gale</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Jenny</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Santiago</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Felix</LastName><ForeName>Adrian</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lovett</LastName><ForeName>Marlee</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nelson</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Ashley</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garrett</LastName><ForeName>Karly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcia</LastName><ForeName>Abigail De La Rosa</ForeName><Initials>AR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rede</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pabon</LastName><ForeName>Marissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Kamran</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fetouh</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woodcook</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kamp</LastName><ForeName>Cornelia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGarry</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torti</LastName><ForeName>Margherita</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>28</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37245090</ArticleId><ArticleId IdType="doi">10.1002/ana.26714</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Saville BR, Berry SM. Efficiencies of platform clinical trials: a vision of the future. Clin Trials 2016;13:358-366.</Citation></Reference><Reference><Citation>Woodcock J, LaVange LM. Master protocols to study multiple therapies, multiple diseases, or both. N Engl J Med 2017;377:62-70.</Citation></Reference><Reference><Citation>Berry SM, Connor JT, Lewis RJ. The platform trial: an efficient strategy for evaluating multiple treatments. JAMA 2015;313:1619-1620.</Citation></Reference><Reference><Citation>Food and Drug Administration Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Research Oncology Center of Excellence. Master protocols: efficient clinical trial design strategies to expedite development of oncology. Drugs and Biologics 2018; FDA-2018-D-3292.</Citation></Reference><Reference><Citation>Alexander BM, Ba S, Berger MS, et al. Adaptive global innovative learning environment for glioblastoma: GBM AGILE. Clin Cancer Res 2018;24:737-743.</Citation></Reference><Reference><Citation>Barker AD, Sigman CC, Kelloff GJ, et al. I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther 2009;86:97-100.</Citation></Reference><Reference><Citation>Papadimitrakopoulou V, Lee JJ, Wistuba II, et al. The BATTLE-2 study: a biomarker-integrated targeted therapy study in previously treated patients with advanced non-small-cell lung cancer. J Clin Oncol 2016;34:3638-3647.</Citation></Reference><Reference><Citation>Parker CC, James ND, Brawley CD, et al. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet 2018;392:2353-2366.</Citation></Reference><Reference><Citation>Simon R. Critical review of umbrella, basket, and platform designs for oncology clinical trials. Clin Pharmacol Ther 2017;102:934-941.</Citation></Reference><Reference><Citation>Bateman RJ, Benzinger TL, Berry S, et al. The DIAN-TU next generation Alzheimer's prevention trial: adaptive design and disease progression model. Alzheimers Dement 2017;13:8-19.</Citation></Reference><Reference><Citation>Mills SM, Mallmann J, Santacruz AM, et al. Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev Neurol 2013;169:737-743.</Citation></Reference><Reference><Citation>Paganoni S, Berry JD, Quintana M, et al. Adaptive platform trials to transform amyotrophic lateral sclerosis therapy development. Ann Neurol 2022;91:165-175. https://doi.org/10.1002/ana.26285.</Citation></Reference><Reference><Citation>Connick P, De Angelis F, Parker RA, et al. Multiple sclerosis- secondary progressive multi-arm randomisation trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. BMJ Open 2018;8:e021944.</Citation></Reference><Reference><Citation>Huang DT, McCreary EK, Bariola JR, et al. The UPMC OPTIMISE-C19 (OPtimizing treatment and impact of monoclonal antIbodieS through evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization. Trials 2021;22:363. https://doi.org/10.1186/s13063-021-05316-3.</Citation></Reference><Reference><Citation>Angus DC, Berry S, Lewis RJ, et al. The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design. Ann Am Thorac Soc 2020;17:879-891.</Citation></Reference><Reference><Citation>Angus DC, Derde L, Al-Beidh F, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA 2020;324:1317-1329.</Citation></Reference><Reference><Citation>Hayward G, Butler CC, Yu L, et al. Platform randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk. BMJ Open 2021;11:e046799. https://doi.org/10.1136/bmjopen-2020-046799.</Citation></Reference><Reference><Citation>Food and Drug Administration Center for Drug Evaluation and Research. Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry, 2019. FDA-2013-N0035.</Citation></Reference><Reference><Citation>Berry JD, Miller R, Moore DH, et al. The combined assessment of function and survival (CAFS): a new endpoint for ALS clinical trials. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:162-168. https://doi.org/10.3109/21678421.2012.762930.</Citation></Reference><Reference><Citation>Gelman A, Shalizi CR. Philosophy and the practice of Bayesian statistics. Br J Math Stat Psychol 2013;66:8-38.</Citation></Reference><Reference><Citation>Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health-care evaluation. Chichester: Wiley, 2004.</Citation></Reference><Reference><Citation>Food and Drug Administration Center for Devices and Radiological Health, Center for Biologics Evaluation and Research. Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials, February 2010.</Citation></Reference><Reference><Citation>Viele K, Berry S, Neuenschwander B, et al. Use of historical control data for assessing treatment effects in clinical trials. Pharm Stat 2014;13:41-54.</Citation></Reference><Reference><Citation>Food and Drug Administration Center for Drug Evaluation and Research. Center for Biologics Evaluation and Research Adaptive Designs for Clinical Trials of Drugs and Biologics, November 2019.</Citation></Reference><Reference><Citation>McGlothlin AE, Viele K. Bayesian hierarchical models. JAMA 2018;320:2365-2366.</Citation></Reference><Reference><Citation>Lim J, Walley R, Yuan J, et al. Minimizing patient burden through the use of historical subject-level data in innovative confirmatory clinical trials: review of methods and opportunities. Ther Innov Regul Sci 2018;52:546-559. https://doi.org/10.1177/2168479018778282.</Citation></Reference><Reference><Citation>Jansen JP, Crawford B, Bergman G, Stam W. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health 2008;11:956-964.</Citation></Reference><Reference><Citation>Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res 2001;10:277-303.</Citation></Reference><Reference><Citation>Smith TC, Spiegelhalter DJ, Thomas A. Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med 1995;14:2685-2699.</Citation></Reference><Reference><Citation>Gamalo-Siebers M, Savic J, Basu C, et al. Statistical modeling for Bayesian extrapolation of adult clinical trial information in pediatric drug evaluation. Pharm Stat 2017 Jul;16:232-249. https://doi.org/10.1002/pst.1807.</Citation></Reference><Reference><Citation>Lake SL, Quintana MA, Broglio K, et al. Bayesian adaptive design for clinical trials in Duchenne muscular dystrophy. Stat Med 2021;40:4167-4184.</Citation></Reference><Reference><Citation>Berry SM, Broglio KR, Groshen S, Berry DA. Bayesian hierarchical modeling of patient subpopulations: efficient designs of phase II oncology clinical trials. Clin Trials 2013;10:720-734.</Citation></Reference><Reference><Citation>Broglio KR, Zhang F, Binbing Y, et al. A comparison of different approaches to Bayesian hierarchical models in a basket trial to evaluate the benefits of increasing complexity. Statistics in Biopharmaceutical Research 2021;14:324-333. https://doi.org/10.1080/19466315.2021.2008484.</Citation></Reference><Reference><Citation>Subbiah V, Lassen PU, Elez E, et al. Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial. Lancet Oncol 2020;21:1234-1243.</Citation></Reference><Reference><Citation>Food and Drug Administration Center for Drug Evaluation and Research. Center for Biologics Evaluation and Research. Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products, December 2020.</Citation></Reference><Reference><Citation>van Eijk RP, Eijkemans MJ, Rizopoulos D, et al. Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis. Clin Epidemiol 2018;10:333-341.</Citation></Reference><Reference><Citation>Van Eijk RP, Roes KCB, Greef-van der Sandt I, et al. Functional loss and mortality in randomized clinical trials for amyotrophic lateral sclerosis: to combine, or not to combine-that is the Estimand. Clin Pharmacol Ther 2022;111:817-825. https://doi.org/10.1002/cpt.2533.</Citation></Reference><Reference><Citation>Wang G, Berry S, Xiong C, et al. A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease. Stat Med 2018;37:3047-3055.</Citation></Reference><Reference><Citation>Quintana M, Shrader J, Slota C, et al. Bayesian model of disease progression in GNE myopathy. Stat Med 2019;38:1459-1474.</Citation></Reference><Reference><Citation>Atassi N, Berry J, Shui A, et al. The PRO-ACT database: design, initial analyses, and predictive features. Neurology 2014;83:1719-1725.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>